IVF (In Vitro Fertilization) and embryo screening have become increasingly discussed topics among couples seeking fertility treatment, often involving both hope and misunderstanding. In this edition ...

UK Biobank is a major biomedical database and research resource, holding the genetic, health, and lifestyle information of half a million adult volunteers. Its datasets are accessible to approved ...

Genomic Prediction, Inc., the frontrunner in advanced embryo screening, today announced the appointment of Santiago Munné, Ph.D., as Chief Scientific Officer. A globally recognized leader in ...

UK Biobank is a large biomedical database containing genetic, health, and lifestyle data from about 500,000 volunteers, intended to support health research in the public interest.  Gulzaar Barn ...

The preimplantation genetic testing market is projected to surge from USD 690.2 million in 2025 to USD 1.13 billion by 2030, reflecting a robust CAGR of 10.5%. Key growth drivers include rising ...

Monash IVF has reached a settlement with the families connected to two embryo mix-ups at its clinics in Melbourne and ...

The reproductive tech company Orchid recently launched a genetic test that promises a whole genome sequencing report for ...

We acknowledge Aboriginal and Torres Strait Islander peoples as the First Australians and Traditional Custodians of the lands where we live, learn and work.

Companies now offer polygenic embryo selection to prospective parents undergoing IVF. But the technology is dangerously underregulated.

Nucleus Genomics today introduced Preview, a new approach to carrier screening that expands what couples can learn before conception. By combining rare and chronic disease screening with trait ...

Live Science spoke with a bioethicist and sociologist about emerging genomic technologies, including those that enable parents to "score" and "select" IVF embryos.

An Australian fertility giant has posted a profit plunge after a series of scandals – including incidents where the wrong ...